Task: Answer the multiple-choice question.
Query: Which compound exhibits a 7.917% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1nc2ccccn2c1-c1csc(Nc2cccc(C(=O)O)c2)n1
b) Cn1c(SCC(=O)Nc2ccc(Cl)cc2)nc(O)cc1=O
Answer: b. Cn1c(SCC(=O)Nc2ccc(Cl)cc2)nc(O)cc1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(SCC(=O)Nc2ccc(Cl)cc2)nc(O)cc1=O
Cn1c(SCC(=O)Nc2ccc(Cl)cc2)nc(O)cc1=O
N-(4-chlorophenyl)-2-(4-hydroxy-1-methyl-6-oxopyrimidin-2-yl)sulfanylacetamide